139 related articles for article (PubMed ID: 34121687)
1. Differential effect of body mass index by gender on oncological outcomes in patients with renal cell carcinoma.
Balci M; Glaser ZA; Chang SS; Herrell SD; Barocas DA; Keegan KA; Moses KA; Resnick MJ; Smith JA; Penson DF; Scarpato K; Clark PE
J Cancer Res Ther; 2021; 17(2):420-425. PubMed ID: 34121687
[TBL] [Abstract][Full Text] [Related]
2. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC).
Fukushima H; Saito K; Yasuda Y; Tanaka H; Patil D; Cotta BH; Patel SH; Master VA; Derweesh IH; Fujii Y
Clin Genitourin Cancer; 2020 Apr; 18(2):111-116.e1. PubMed ID: 32001181
[TBL] [Abstract][Full Text] [Related]
3. Recurrence after radical and partial nephrectomy in high complex renal tumor using propensity score matched analysis.
Kim H; Kim JK; Ye C; Choi JH; Lee H; Oh JJ; Lee S; Hong SK; Byun SS
Sci Rep; 2021 Feb; 11(1):2919. PubMed ID: 33536492
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.
Hamilton ZA; Capitanio U; Pruthi D; Ghali F; Larcher A; Patel DN; Eldefrawy A; Patel S; Cotta BH; Bradshaw AW; Meagher MF; Miller NS; Carenzi C; Wan F; Liss MA; McGregor T; Montorsi F; Derweesh IH
Urology; 2020 Apr; 138():60-68. PubMed ID: 31836465
[TBL] [Abstract][Full Text] [Related]
5. Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma.
Chen SH; Xu LY; Wu YP; Ke ZB; Huang P; Lin F; Li XD; Xue XY; Wei Y; Zheng QS; Xu N
BMC Cancer; 2021 Jan; 21(1):79. PubMed ID: 33468079
[TBL] [Abstract][Full Text] [Related]
6. Influence of nutritional deficiency on prognosis of renal cell carcinoma (RCC).
Ko K; Park YH; Lee JW; Ku JH; Kwak C; Kim HH
BJU Int; 2013 Oct; 112(6):775-80. PubMed ID: 24028765
[TBL] [Abstract][Full Text] [Related]
7. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of prognostic nutritional index in renal cell carcinomas.
Tang Y; Liang J; Liu Z; Zhang R; Zou Z; Wu K; Lu Y; Wei X
Medicine (Baltimore); 2021 Mar; 100(10):e25127. PubMed ID: 33725913
[TBL] [Abstract][Full Text] [Related]
9. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
10. Extreme obesity does not predict poor cancer outcomes after surgery for renal cell cancer.
Blute ML; Zorn K; Grimes M; Shi F; Downs TM; Jarrard DF; Best SL; Richards K; Nakada SY; Abel EJ
BJU Int; 2016 Sep; 118(3):399-407. PubMed ID: 26589741
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of body mass index in Asian patients with localized renal cell carcinoma.
Komura K; Inamoto T; Black PC; Koyama K; Katsuoka Y; Watsuji T; Azuma H
Nutr Cancer; 2011; 63(6):908-15. PubMed ID: 21800976
[TBL] [Abstract][Full Text] [Related]
12. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract][Full Text] [Related]
13. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.
Shah PH; Moreira DM; Patel VR; Gaunay G; George AK; Alom M; Kozel Z; Yaskiv O; Hall SJ; Schwartz MJ; Vira MA; Richstone L; Kavoussi LR
J Urol; 2017 Aug; 198(2):289-296. PubMed ID: 28274620
[TBL] [Abstract][Full Text] [Related]
14. Pre-existing type 2 diabetes is an adverse prognostic factor in patients with renal cell carcinoma.
Yang H; Yin K; Wang Y; Xia M; Zhang R; Wang W; Chen J; Wang C; Shuang W
J Diabetes; 2019 Dec; 11(12):993-1001. PubMed ID: 31141620
[TBL] [Abstract][Full Text] [Related]
15. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system.
Cho MC; Kim JK; Moon KC; Kim HH; Kwak C
Int Braz J Urol; 2013; 39(3):353-63. PubMed ID: 23849567
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of body mass index and other tumor and patient characteristics in non-metastatic renal cell carcinoma.
Ahmedov V; Kizilay F; Cüreklibatir I
Urol J; 2018 May; 15(3):96-103. PubMed ID: 29464679
[TBL] [Abstract][Full Text] [Related]
19. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
[TBL] [Abstract][Full Text] [Related]
20. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
